Catherine has been a Gastroenterologist and Hepatologist at Christchurch Hospital, and also a Clinical Senior Lecturer for the University of Otago since 2005. She undertook medical training through the University of Otago and completed FRACP specialist training in both Gastroenterology/Hepatology and Clinical Pharmacology, followed by PhD studies in Molecular Pharmacology and Hepatology at the Storr Liver Unit, in Sydney Australia.
She is currently actively involved in all aspects of clinical gastroenterology and has a strong interest in Hepatitis C new oral drug development. She has been principal investigator for over 40 clinical trials from phase 1 through to phase 3. She has been a significant contributor to several pivotal proof of concept interferon free trials for hepatitis C treatment over the past 5 years.
| Update on Hep B and Hep C
Nurses Programme |
|||
| Saturday, 16 August 2014 | Start 11:30am | Duration: 30mins | Westpac |
| Community/GP based screening and management of HCV and HBV
Concurrent Workshop Repeated |
|||
| Saturday, 16 August 2014 | Start 2:00pm | Duration: 55mins | Room 8 |
| Start 3:05pm | Duration: 55mins | Room 8 | |
| The majority
of patients with viral hepatitis are asymptomatic for many years,
and often do not present until they have late complications such as
liver failure or liver cancer. GPs are the key health professional
to identify patients at risk of viral hepatitis and offer testing to
diagnose Hepatitis B and C, so that appropriate treatment can be
offered to prevent life threatening complications.
Case-based discussion will be used to help identify risk factors and also update GPs on new non-invasive methods of liver assessment for both hepatitis B and C, as well as a brief overview of the major changes towards interferon free treatment of hepatitis C. |
|||